Haleon plc (HLN.L)
Makes and sells over-the-counter pain relief, cold medicine, and oral health products worldwide.
380.90+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+4.2%
The outlook
Haleon is trading near the top of its 52-week range with analyst sentiment leaning bullish—the consensus average sits at "Buy" across 17 analysts. The stock sits above both its 50- and 200-day moving averages, and the average price target implies roughly 9% upside from current levels. The trailing P/E stands at 20.0.
What’s behind the score
Analyst consensusBuy — 2.1 avg of 17 analysts
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Price targetAvg target +9% vs current price
Analyst price target
~12-month · 17 analysts414.24average target+8.8% vs now
Now 380.90
Low 315.00High 512.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$33.55B
52-wk high
416.10
52-wk low
0.00
50-day avg
347.63
200-day avg
363.29
Trailing P/E
20.0